Outset Medical, Inc.
OMNASDAQHealthcare● Active
$4.32
$-0.26(-5.68%)
Market Cap$80080704
P/E Ratio—
52W High$21.98
52W Low$3
Outset Medical, Inc. (OM) Earnings: Dates, EPS & Revenue History
Quarterly EPS vs. estimates, revenue surprises, next earnings date, and analyst consensus.
OM · earnings · updated Jun 8, 2026
Latest Earnings
Q2 FY2026Report Date: May 7, 2026EPS Actual
-$0.83
Est. -$0.79 · -5.1%
Revenue
$0.03B
Est. $0.03B · -3.5%
Fiscal Period
Q2 FY2026
FY ends December
Report Date
May 7, 2026
After Market Close
▼ Miss EPS▼ Miss Revenue
OM reports quarterly as a NASDAQ-listed Medical - Devices company. Fiscal year ends in December. Data: FMP · Updated hourly.
Next Earnings Date
Days Away
85
days
Expected Date
Sep 1, 2026
Fiscal Period
Q3 FY2026
Release Time
◌ Time TBD (Unconfirmed)EPS Est.
$0.21
Rev. $0.66B
Days Away85
Expected DateSep 1, 2026
Fiscal PeriodQ3 FY2026
Release TimeTime TBD (Unconfirmed)
EPS Est.$0.21
Rev. Est.$0.66B
EPS & Revenue vs. Estimates
Actual (Beat)
Actual (Miss)
Estimated
Earnings History
| Period | Report Date | EPS Est. | EPS Actual | EPS Surpr. | Revenue | Rev. Est. | Rev. Surpr. |
|---|---|---|---|---|---|---|---|
| ◌ Q3 FY2026 | Aug 5, 2026 | -$0.72 | — | — | — | $0.03B | — |
| ▼ Q2 FY2026 | May 7, 2026 | -$0.79 | -$0.83 | -5.1% | $0.03B | $0.03B | -3.5% |
| ▼ Q1 FY2026 | Feb 11, 2026 | -$0.67 | -$0.84 | -24.6% | $0.03B | $0.03B | +8.4% |
| ▼ Q4 FY2025 | Nov 10, 2025 | -$0.66 | -$0.69 | -5.3% | $0.03B | $0.03B | -4.1% |
| ▲ Q3 FY2025 | Aug 6, 2025 | -$0.98 | -$0.84 | +14.5% | $0.03B | $0.03B | +6.8% |
| ▼ Q2 FY2025 | May 7, 2025 | -$0.94 | -$3.24 | -242.9% | $0.03B | $0.03B | +7.0% |
| ▲ Q1 FY2025 | Feb 19, 2025 | -$6.20 | -$5.55 | +10.5% | $0.03B | $0.03B | +3.5% |
| ▼ Q4 FY2024 | Nov 6, 2024 | -$0.40 | -$5.85 | -1362.5% | $0.03B | $0.03B | +6.6% |
Q3 FY2026
Aug 5, 2026
EPS Actual
—
EPS Est.
-$0.72
EPS Surpr.
—
Revenue
—
Q2 FY2026
May 7, 2026Miss
EPS Actual
-$0.83
EPS Est.
-$0.79
EPS Surpr.
-5.1%
Revenue
$0.03B
Q1 FY2026
Feb 11, 2026Miss
EPS Actual
-$0.84
EPS Est.
-$0.67
EPS Surpr.
-24.6%
Revenue
$0.03B
Q4 FY2025
Nov 10, 2025Miss
EPS Actual
-$0.69
EPS Est.
-$0.66
EPS Surpr.
-5.3%
Revenue
$0.03B
Q3 FY2025
Aug 6, 2025Beat
EPS Actual
-$0.84
EPS Est.
-$0.98
EPS Surpr.
+14.5%
Revenue
$0.03B
Q2 FY2025
May 7, 2025Miss
EPS Actual
-$3.24
EPS Est.
-$0.94
EPS Surpr.
-242.9%
Revenue
$0.03B
Q1 FY2025
Feb 19, 2025Beat
EPS Actual
-$5.55
EPS Est.
-$6.20
EPS Surpr.
+10.5%
Revenue
$0.03B
Q4 FY2024
Nov 6, 2024Miss
EPS Actual
-$5.85
EPS Est.
-$0.40
EPS Surpr.
-1362.5%
Revenue
$0.03B
Analyst Estimates
Limited analyst coverage (fewer than 3 analysts). Estimates may not reflect market consensus.
EPS Estimates
| Period | Low | Consensus | High | # Analysts |
|---|---|---|---|---|
| Q4 FY2027 | $-0.63 | $-0.61 | $-0.59 | 1 |
| Q3 FY2027 | $-0.56 | $-0.54 | $-0.52 | 1 |
| Q2 FY2027 | $-0.70 | $-0.67 | $-0.65 | 1 |
| Q1 FY2027 | $-0.77 | $-0.74 | $-0.72 | 1 |
| Q4 FY2026 | $-0.76 | $-0.73 | $-0.71 | 1 |
| Q3 FY2026 | $-0.64 | $-0.62 | $-0.60 | 2 |
Revenue Estimates
| Period | Low | Consensus | High | # Analysts |
|---|---|---|---|---|
| Q4 FY2027 | $0.0B | $0.0B | $0.0B | 1 |
| Q3 FY2027 | $0.0B | $0.0B | $0.0B | 1 |
| Q2 FY2027 | $0.0B | $0.0B | $0.0B | 1 |
| Q1 FY2027 | $0.0B | $0.0B | $0.0B | 1 |
| Q4 FY2026 | $0.0B | $0.0B | $0.0B | 1 |
| Q3 FY2026 | $0.0B | $0.0B | $0.0B | 2 |
Earnings Price Reaction
Closing price one trading day before vs. one trading day after each earnings release.
| Period | Report Date | EPS Beat/Miss | Price Before | Price After | 1D Reaction |
|---|---|---|---|---|---|
| ▼ Q2 FY2026 | May 7, 2026 | -5.1% | $4.51 | $4.68 | +3.77% |
| ▼ Q1 FY2026 | Feb 11, 2026 | -24.6% | $4.70 | $4.54 | -3.40% |
| ▼ Q4 FY2025 | Nov 10, 2025 | -5.3% | $12.06 | $12.07 | +0.08% |
| ▲ Q3 FY2025 | Aug 6, 2025 | +14.5% | $14.10 | $13.17 | -6.60% |
| ▼ Q2 FY2025 | May 7, 2025 | -242.9% | $11.54 | $11.74 | +1.73% |
| ▲ Q1 FY2025 | Feb 19, 2025 | +10.5% | $13.62 | $14.10 | +3.52% |
| ▼ Q4 FY2024 | Nov 6, 2024 | -1362.5% | $9.41 | $9.30 | -1.17% |
| ▼ Q3 FY2024 | Aug 7, 2024 | -5.3% | $52.80 | $51.00 | -3.41% |
Q2 FY2026+3.77%
Report Date
May 7, 2026
EPS Beat/Miss
-5.1%
Price Before
$4.51
Price After
$4.68
Q1 FY2026-3.40%
Report Date
Feb 11, 2026
EPS Beat/Miss
-24.6%
Price Before
$4.70
Price After
$4.54
Q4 FY2025+0.08%
Report Date
Nov 10, 2025
EPS Beat/Miss
-5.3%
Price Before
$12.06
Price After
$12.07
Q3 FY2025-6.60%
Report Date
Aug 6, 2025
EPS Beat/Miss
+14.5%
Price Before
$14.10
Price After
$13.17
Q2 FY2025+1.73%
Report Date
May 7, 2025
EPS Beat/Miss
-242.9%
Price Before
$11.54
Price After
$11.74
Q1 FY2025+3.52%
Report Date
Feb 19, 2025
EPS Beat/Miss
+10.5%
Price Before
$13.62
Price After
$14.10
Q4 FY2024-1.17%
Report Date
Nov 6, 2024
EPS Beat/Miss
-1362.5%
Price Before
$9.41
Price After
$9.30
Q3 FY2024-3.41%
Report Date
Aug 7, 2024
EPS Beat/Miss
-5.3%
Price Before
$52.80
Price After
$51.00
Avg Beat Reaction-1.54%
Avg Miss Reaction-0.40%
Beat Rate2 / 8 quarters
Largest Move-6.60% (Q3 FY2025)
Data: FMP /historical-price-eod/full · field: close
About Earnings & Data Methodology
Data source: Financial Modeling Prep (FMP) | Updated: Hourly | Surprise%: (Actual − Estimate) / |Estimate| × 100 | Fiscal year: OM ends December
Outset Medical, Inc. (OM) most recently reported earnings on May 7, 2026 for Q2 FY2026, posting EPS of $-0.83 — missing the analyst consensus of $-0.79 by -5.1%. The next OM earnings date is expected around September 1, 2026.
Each quarter, investors track OM earnings for signals on forward guidance and business momentum. For longer-term revenue trends, see the Revenue tab. OM revenue tab →
Earnings Glossary
EPS (Earnings Per Share)
Net income ÷ diluted shares outstanding. The primary metric analysts use to gauge quarterly profitability.
Earnings Surprise %
(Actual − Estimate) / |Estimate| × 100. Positive = Beat. Negative = Miss.
Beat / Miss / In-Line
Beat = Actual ≥ Estimate. Miss = Actual < Estimate. In-Line = within ±1%.
BMO / AMC
Before Market Open / After Market Close. Two windows when companies typically release results.
Fiscal Quarter
OM's fiscal year ends in December. Fiscal quarters may not align with calendar quarters.
Analyst Consensus
Average EPS/Revenue forecast across all covering analysts. More analysts = more reliable estimate.
Figures tie to FMP earnings calendar, estimates, and SEC 10-Q/10-K filings where noted.
Frequently asked questions
OM earnings · 5 questionsOutset Medical, Inc.'s next earnings report is expected around September 1, 2026. OM typically reports quarterly — approximately every three months. The exact date is confirmed by the company 2–4 weeks before the release. Time is currently TBD; OM historically reports after market close (AMC).
OM earnings datewhen is OM earningsOM next earnings datewhen does OM report earningsOM earnings calendar
▸ Source: FMP · Outset Medical, Inc. SEC filings · US GAAP · Outset Medical, Inc. SEC 10-K & 10-Q filings · US GAAP · Updated: Jun 8, 2026